Our Scans · (ZY.3.05) Biology · Weekly Summary

• AI is poised to shrink the world's health gap and accelerate discovery in physics, chemistry, and biology, leading to more personalized learning experiences and a future where every research scientist could have an AI lab assistant. TashiOS
• Germany's strong industrial base provides additional opportunities for the integration of computational biology into pharmaceutical development and biotechnology. Straits Research
• The MIT-IBM Computing Research Lab will focus on quantum algorithms and hybrid computing systems, targeting breakthroughs in materials science, chemistry, and biology. Quantum Computing Report
• BMS invests in novel therapeutic platforms like targeted protein degradation, cell therapy, and radiopharmaceuticals that have the potential to unlock targets with strong causal human biology. Plenge Gen @rplenge
• Genomics is only one layer of biology, and Yossi expects 2026 to bring much more practical attention to proteins. Fulcrum Genomics
• The ability to read, write, and edit genetic code, which has rendered biology programmable has led the U.S. government to believe that biotechnology will play an outsized importance over the coming decade, particularly in the context of geopolitical competition. Council on Foreign Relations
• NVIDIA research and development teams will use Ceiba to advance AI for LLMs, graphics (image/video / 3D generation) and simulation, digital biology, robotics, self-driving cars, NVIDIA Earth-2 climate prediction, and more to help NVIDIA propel future generative AI innovation. insideBIGDATA
• Deepcell, which already uses the NVIDIA A4000 and NVIDIA AI technology, will incorporate NVIDIA AI into its single cell analysis technology, working collaboratively with NVIDIA to codevelop new uses for generative AI and multimodal applications in cell biology. MarketScreener
• Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, and Cibus, a leader in precision gene editing in agriculture, has announced that they will merge in an all-stock transaction. iGrow News
• Boundaries between disciplines will significantly blur in 2026 due to overlapping immunology biology. PharmaVOICE

Last updated: 14 September 2026